首页 › 基金 › PFM Health Sciences, LP › DNTH
PFM Health Sciences, LP 对 DNTH 的持仓历史
DIANTHUS THERAPEUTICS INC · 医疗保健
PFM Health Sciences, LP 在 Q2 2026 的 13F 申报中披露持有 DNTH(DIANTHUS THERAPEUTICS INC)121,222 股,市值约 US$11.8M,约占其申报组合的 1.04%,在其申报持仓中市值排名第 35 位。 PFM Health Sciences, LP 最近 4 个申报季度中有 4 个季度披露了 DNTH 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
PFM Health Sciences, LP 对 DNTH 的持仓演变
PFM Health Sciences, LP 于 Q3 2025 首次披露 DNTH 持仓:67,840 股(约 US$2.7M)。 该持仓在 Q1 2026 达到峰值 172,137 股,市值约 US$14.4M。 在 4 次申报中,PFM Health Sciences, LP 2 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 121,222 股、市值约 US$11.8M,环比减持 -50,915 股。。 持仓曾出现大幅变动:Q4 2025 增持约 47% (随后一个季度股价上涨 104%)、Q1 2026 增持约 73% (随后一个季度股价上涨 16%)、Q2 2026 减持约 30% (随后一个季度股价下跌 10%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 67.84K | $2.67M | 新进 |
| Q4 2025 | 99.58K | $4.10M | 增持 |
| Q1 2026 | 172.14K | $14.45M | 增持 |
| Q2 2026 | 121.22K | $11.82M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 DNTH 与 13F 数据
DNTH(DIANTHUS THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 73 只申报持有 DNTH,申报仓位最大的包括:Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 DNTH 的基金
- Fairmount Funds Management LLC 2.54M 股 · $247.33M · Q2 2026
- Avidity Partners Management LP 2.10M 股 · $205.12M · Q2 2026
- Octagon Capital Advisors LP 1.84M 股 · $179.53M · Q2 2026
- TCG Crossover Management, LLC 1.68M 股 · $163.44M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 1.30M 股 · $126.97M · Q2 2026
- Venrock Adviser, LLC 1.18M 股 · $115.03M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.13M 股 · $109.70M · Q2 2026
- BAKER BROS. ADVISORS LP 852.16K 股 · $83.07M · Q2 2026
- Logos Global Management LP 800.00K 股 · $77.98M · Q2 2026
- Cormorant Asset Management, LP 750.00K 股 · $73.11M · Q2 2026
- BRAIDWELL LP 594.56K 股 · $57.96M · Q2 2026
- MPM BioImpact LLC 420.00K 股 · $40.94M · Q2 2026
更多关于 PFM Health Sciences, LP
常见问题
How long has PFM Health Sciences, LP held DNTH?
PFM Health Sciences, LP has disclosed DNTH holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is PFM Health Sciences, LP's current position in DNTH?
As of Q2 2026, PFM Health Sciences, LP holds 121.22K shares of DNTH (DIANTHUS THERAPEUTICS INC), valued at $11.82M, representing 1.04% of its reported portfolio and ranking #35.
Has PFM Health Sciences, LP been buying or selling DNTH?
In the latest 13F filing (Q2 2026), PFM Health Sciences, LP reduced its position in DNTH. The position peaked in Q1 2026 at 172.14K shares.
Which other funds hold DNTH?
Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.